Procter & Gamble Health Share Price

NSE: PGHL

₹ 6,714.00

+₹10.50 (0.16%)

Last updated 24 Jul, 2026, 15:55 IST

Procter & Gamble Health Share Price Today

As of 25 Jul 2026, Procter & Gamble Health share price is ₹6,714.00. The stock opened at ₹6,673.50, compared to its previous close of ₹6,703.50. During today's trading session, Procter & Gamble Health share price moved in the range of ₹6,631.50 to ₹6,745.00, with an average price of ₹6,688.25 for the day. Looking at its last 52-week, the stock has touched a low of ₹4,707.00 and a high of ₹6,975.00. On the performance front, Procter & Gamble Health share price has increased by 24.44% over the last six months and is up 15.20% on a year-on-year basis.

₹6,631.50

0.16% up today

₹6,745.00

1D LOW

1D HIGH

Stock Performance

OutperformingBeat Nifty by 7.87 % in last 1 month

Shareholding Pattern

DIIDII decreased stake by 2.47%

Shareholding Pattern

FIIFII increased stake by 2.13%

Procter & Gamble Health Returns Calculator

If you would've invested

₹

₹1,000₹1Cr

Historical Returns

1 Year

₹5,77,747+₹77,747 (+15.55%)

3 Year

₹6,24,146+₹1,24,146 (+24.83%)

5 Year

₹6,26,610+₹1,26,610 (+25.32%)

₹5,363.00₹8,044.00

Circuit Low

Circuit High

₹4,707.00₹6,975.00

52-Week Low

52-Week High

Circuit

₹5,363.00

₹8,044.00

52-week

₹4,707.00

₹6,975.00

Mkt Cap Cr

11,127.00

P/E

34.04

P/B

21.21

ROE

62.32%

D/E

0.02

ROCE

84.14%

Div. Yield

6.19%

EPS(TTM)

196.94

Turnover

2.40

EV/EBITDA

23.13

Net Margin

0.00%

Op. Margin

0.00%

ROA

38.86%

Quick Ratio

0.00

Curr. Ratio

2.21

Mkt Cap Cr

11,127.00

P/E

34.04

P/B

21.21

ROE

62.32%

D/E

0.02

ROCE

84.14%

Div. Yield

6.19%

EPS(TTM)

196.94

Turnover

2.40

EV/EBITDA

23.13

Net Margin

0.00%

Op. Margin

0.00%

ROA

38.86%

Quick Ratio

0.00

Curr. Ratio

2.21

Based on fundamentals, this stock's

Performance

Excellent

P & G Health Ltd outperforming all market indices

Valuation

Overvalued

P & G Health Ltd appears overvalued compared to its peers

Peer Comparison

Peer comparison — key ratios
Name	Mkt Cap Cr	P/E	P/B	ROE	D/E	ROCE	Book Value	Div. Yield	Turnover	EPS(TTM)
Sun Pharmaceutical Industries	4,65,711.00	36.73	5.05	14.85%	0.55	18.72%	18.85	0.91%	0.56	10.90
Divis Laboratories	1,93,860.00	61.36	9.40	16.19%	0.00	21.00%	9.43	0.50%	0.58	98.19
Torrent Pharmaceuticals	1,92,687.00	66.03	17.03	26.76%	1.05	18.30%	16.90	0.90%	0.49	64.75
Cipla	1,12,593.00	33.55	3.27	11.27%	0.00	14.95%	423.36	0.93%	0.44	43.52
Zydus Lifesciences	1,11,082.00	17.39	3.23	19.69%	0.35	20.30%	3.70	0.11%	0.39	35.38
Lupin	1,09,553.00	19.83	4.71	27.01%	0.03	27.44%	3.51	0.78%	0.61	129.18
Mankind Pharma	1,05,607.00	1.05	0.12	12.65%	0.42	12.97%	5.05	0.05%	0.54	49.37
Dr. Reddy's Laboratories	96,204.70	30.22	2.53	11.07%	0.18	12.54%	377.96	0.69%	0.41	38.68
Aurobindo Pharma	88,508.40	25.27	2.34	9.25%	0.19	11.76%	391.14	0.26%	0.48	41.58
Laurus Labs	84,727.30	60.26	10.10	18.21%	0.40	16.70%	97.21	0.12%	0.64	13.72

Procter & Gamble Health Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
Particulars	Mar 2025	Jun 2024	Jun 2023	Jun 2022
Revenue	₹934.17	₹1,151.26	₹1,229.62	₹1,114.41
Other Income	₹10.35	₹15.63	₹18.39	₹13.19
Total Revenue	₹944.52	₹1,166.89	₹1,248.01	₹1,127.60
Total Expenses	₹632.90	₹873.38	₹933.81	₹874.23
Profit Before Tax	₹311.62	₹273.32	₹314.20	₹253.37
Tax	₹77.21	₹72.34	₹84.73	₹60.85
Profit After Tax	₹234.41	₹200.98	₹229.47	₹192.52
EPS - Basic	₹141.00	₹121.00	₹138.00	₹116.00
EPS - Diluted	₹141.00	₹121.00	₹138.00	₹116.00

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
Particulars	Mar 2025	Jun 2024	Jun 2023	Jun 2022
Profit before tax	₹311.62	₹273.32	₹314.20	₹253.37
Income before WC changes	₹323.82	₹325.59	₹355.69	₹280.68
Change in Assets	-₹69.92	₹70.57	-₹97.15	-₹49.18
Change in Liabilities	-₹3.89	-₹82.68	₹67.13	₹1.88
Change in WC	-₹73.81	-₹12.11	-₹30.02	-₹47.30
Cash flow from Operations	₹168.69	₹228.29	₹236.01	₹169.52
Cash flow from Investing	₹9.59	-₹6.87	-₹21.50	-₹25.54
Cash flow from Financing	-₹234.74	-₹418.11	-₹98.49	-₹288.63
Total Cash Flow	-₹56.46	-₹196.69	₹116.02	-₹144.65
Cash (Start of the year)	₹238.73	₹435.42	₹319.40	₹464.05
Cash (End of the year)	₹182.27	₹238.73	₹435.42	₹319.40

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
Particulars	Mar 2025	Jun 2024	Jun 2023	Jun 2022
Non-Current Assets	₹267.81	₹270.14	₹305.09	₹280.08
Current Assets	₹526.39	₹524.22	₹796.10	₹608.04
Total Assets	₹794.20	₹794.36	₹1,101.19	₹888.12
Current Liabilities	₹215.31	₹218.91	₹303.90	₹231.90
Net Current Asset	₹311.08	₹305.31	₹492.20	₹376.14
Non-Current Liabilities	₹41.93	₹37.21	₹46.40	₹39.73
Equity Capital	₹536.96	₹538.24	₹750.89	₹616.49
Total Equity & Liabilities	₹794.20	₹794.36	₹1,101.19	₹888.12

* All values are in INR Crore

Qty

Bid

Ask

Qty

6714

Bid Total: 0

Ask Total: 94

Buy orders: 0%

Sell orders: 100%

30 levels of bid & ask depth

Supply & Demand Zones

Bearish

Neutral

Bullish

Neutral

by SEBI experts available for this stock

Earn more using advisory

by SEBI experts

Expert Pick

EXPPICK

Stop-loss

Entry price

Target

Indicator

Value

Verdict

RSI (14)

60.65

Neutral

ATR (14)

186.82

Neutral

STOCH(9,6)

26.42

Neutral

STOCH RSI (14)

22.01

Neutral

ADX(9)

49.35

Bearish

UO(9)

48.65

Neutral

ROC(12)

7.25

Bullish

WillR(14)

-35.15

Neutral

Period

Simple value

Exponential vaue

6769.4

6751.39

10D

6819.3

6728.44

20D

6581.55

6606.16

50D

6196.25

6239.79

100D

5595.35

5911.94

About Procter & Gamble Health

ISIN

INE199A01012

Sector Market Cap

₹ 11,127 Cr

Procter & Gamble Health Limited is an India-based multinational consumer goods company. The Company is focused on manufacturing and marketing of over-the-counter products, vitamins, minerals, and supplements products for a healthy lifestyle. The Company is engaged in the manufacturing and selling of healthcare products, such as vitamins, minerals and supplements. Patients are end consumers of the products. The Company’s distribution channels (direct and indirect), inter alia, include distributors, health care professionals, pharmacies and chemists. The Company’s brands include Polybion, Cosome, Evion, Neurobion, Seven Seas, Nasivion, and Livogen. Cosome is a medicine which is used to help relieve dry coughs and related congestion symptoms. Evion is a Vitamin E capsules. The Seven Seas is a pure vitamin rich cod-liver oil. Neurobion offers a range of neurotropic supplements. Its products are sold in about 180 countries and territories throughout the world.

Procter & Gamble Health Financial Highlights

Revenue: Procter & Gamble Health reported revenue of ₹1,425.31 crore in FY26 vs ₹944.52 crore in FY25. It showed an increase of 50.90% on a yearly basis.
Operating Profit: Procter & Gamble Health reported an operating profit of ₹449.86 crore in FY26 vs ₹311.62 crore in FY25. It showed an increase of 44.36% on a year-on-year basis.
Net Profit: Procter & Gamble Health reported a net profit of ₹326.91 crore in FY26 vs ₹234.41 crore in FY25. It showed an increase of 39.46% on a yearly basis.

Procter & Gamble Health Quarterly Result Highlights

Procter & Gamble Health reported revenue of ₹374.45 crore in Mar 2026, compared with ₹378.22 crore in Dec 2025, representing a decrease of 1.00% on a quarter-on-quarter (QoQ) basis.
Procter & Gamble Health reported an operating profit of ₹133.21 crore in Mar 2026, compared with ₹108.82 crore in Dec 2025, representing an increase of 22.41% on a quarter-on-quarter (QoQ) basis.
Procter & Gamble Health reported a profit of ₹94.60 crore in Mar 2026, compared with ₹77.59 crore in Dec 2025, reflecting an increase of 21.92% on a QoQ basis.
The earnings per share (EPS) of Procter & Gamble Health stood at ₹141.00 during Mar 2026.